Xi Xu
State Key Laboratory Of Natural Medicines, Jiangsu Key Laboratory Of Drug Design And Optimization
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Wogonin-derived chemotype enables discovery of novel GLS1 inhibitors with potent antitumor activity.
Wogonin-derived chemotype enables discovery of novel GLS1 inhibitors with potent antitumor activity.
Journal: Future medicinal chemistry
Published: March 12, 2026
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.
Journal: Journal of virology
Published: December 09, 2025
Discovery of Tricyclic Derivative as Novel and Potent Respiratory Syncytial Virus Fusion Glycoprotein Inhibitor with an Improved Pharmacokinetic Profile.
Journal: Journal of medicinal chemistry
Published: September 11, 2025
Cancer Biology of GSPT1: Mechanisms and Targeted Therapy Opportunities of Molecular Glue Degraders.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 27, 2025
WRN as a Novel Target of Synthetic Lethality: Current Advances and Future Perspectives.
Journal: Journal of medicinal chemistry
Published: June 17, 2025
Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib-Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 18, 2024
Discovery of Highly Potent Solute Carrier 13 Member 5 (SLC13A5) Inhibitors for the Treatment of Hyperlipidemia.
Journal: Journal of medicinal chemistry
Published: April 04, 2024
Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung Cancer.
Journal: Journal of medicinal chemistry
Published: October 23, 2023
Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective.
Journal: Medicinal research reviews
Published: September 20, 2023
Discovery of Selenium-Containing STING Agonists as Orally Available Antitumor Agents.
Journal: Journal of medicinal chemistry
Published: September 07, 2022
Discovery of Potent Small-Molecule USP8 Inhibitors for the Treatment of Breast Cancer through Regulating ERα Expression.
Journal: Journal of medicinal chemistry
Published: July 05, 2022
Preparation, characterization, and antibacterial activity of tigecycline-loaded, ultrasound-activated microbubbles.
Journal: Pharmaceutical development and technology
Published: December 13, 2021
Last Updated: 09/26/2026